Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2007, Article ID 59430, 6 pages
http://dx.doi.org/10.1155/2007/59430
Review Article

CD40-CD40L Interaction in Immunity Against Protozoan Infections

Laboratoire de Bactériologie Moléculaire, Département de Microbiologie, Faculté de Médecine, Université Libre de Bruxelles (U.L.B), 808 Route de Lennik, Bruxelles 1070, Belgium

Received 1 December 2006; Accepted 2 February 2007

Academic Editor: Ali Ouaissi

Copyright © 2007 Mustapha Chamekh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Clark and J. A. Ledbetter, “Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 12, pp. 4494–4498, 1986. View at Publisher · View at Google Scholar
  2. F. Schriever, A. S. Freedman, and G. Freeman et al., “Isolated human follicular dendritic cells display a unique antigenic phenotype,” Journal of Experimental Medicine, vol. 169, no. 6, pp. 2043–2058, 1989. View at Publisher · View at Google Scholar
  3. M. R. Alderson, R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs, “CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 669–674, 1993. View at Publisher · View at Google Scholar
  4. D. Hollenbaugh, N. Mischel-Petty, and C. P. Edwards et al., “Expression of functional CD40 by vascular endothelial cells,” Journal of Experimental Medicine, vol. 182, no. 1, pp. 33–40, 1995. View at Publisher · View at Google Scholar
  5. C. van Kooten and J. Banchereau, “Functions of CD40 on B cells, dendritic cells and other cells,” Current Opinion in Immunology, vol. 9, no. 3, pp. 330–337, 1997. View at Publisher · View at Google Scholar
  6. R. J. Armitage, W. C. Fanslow, and L. Strockbine et al., “Molecular and biological characterization of a murine ligand for CD40,” Nature, vol. 357, no. 6373, pp. 80–82, 1992. View at Publisher · View at Google Scholar · View at PubMed
  7. D. Hollenbaugh, L. S. Grosmaire, and C. D. Kullas et al., “The human T cell antigen GP39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of GP39 with B cell co-stimulatory activity,” The EMBO Journal, vol. 11, no. 12, pp. 4313–4321, 1992.
  8. C. van Kooten and J. Banchereau, “CD40-CD40 ligand,” Journal of Leukocyte Biology, vol. 67, no. 1, pp. 2–17, 2000.
  9. M. Wykes, “Why do B cells produce CD40 ligand?,” Immunology and Cell Biology, vol. 81, no. 4, pp. 328–331, 2003. View at Publisher · View at Google Scholar
  10. T. M. Foy, A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle, “Immune regulation by CD40 and its ligand GP39,” Annual Review of Immunology, vol. 14, pp. 591–617, 1996. View at Publisher · View at Google Scholar · View at PubMed
  11. L. B. Clark, T. M. Foy, and R. J. Noelle, “CD40 and its ligand,” Advances in Immunology, vol. 63, pp. 43–78, 1996.
  12. I. S. Grewal and R. A. Flavell, “A central role of CD40 ligand in the regulation of CD4+ T-cell responses,” Immunology Today, vol. 17, no. 9, pp. 410–414, 1996. View at Publisher · View at Google Scholar
  13. M. Cella, D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber, “Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation,” Journal of Experimental Medicine, vol. 184, no. 2, pp. 747–752, 1996. View at Publisher · View at Google Scholar
  14. I. S. Grewal, P. Borrow, E. G. Pamer, M. B. Oldstone, and R. A. Flavell, “The CD40-CD154 system in anti-infective host defense,” Current Opinion in Immunology, vol. 9, no. 4, pp. 491–497, 1997. View at Publisher · View at Google Scholar
  15. T. H. Watts, “TNF/TNFR family members in costimulation of T cell responses,” Annual Review of Immunology, vol. 23, pp. 23–68, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. L. D. Notarangelo, M. Duse, and A. G. Ugazio, “Immunodeficiency with hyper-IgM (HIM),” Immunodeficiency Reviews, vol. 3, no. 2, pp. 101–121, 1992.
  17. J. Levy, T. Espanol-Boren, and C. Thomas et al., “Clinical spectrum of X-linked hyper-IgM syndrome,” Journal of Pediatrics, vol. 131, no. 1, pp. 47–54, 1997. View at Publisher · View at Google Scholar
  18. D. Sacks and N. Noben-Trauth, “The immunology of susceptibility and resistance to Leishmania major in mice,” Nature Reviews Immunology, vol. 2, no. 11, pp. 845–858, 2002. View at Publisher · View at Google Scholar · View at PubMed
  19. K. A. Campbell, P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski, “CD40 ligand is required for protective cell-mediated immunity to Leishmania major,” Immunity, vol. 4, no. 3, pp. 283–289, 1996. View at Publisher · View at Google Scholar
  20. M. Kamanaka, P. Yu, and T. Yasui et al., “Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity,” Immunity, vol. 4, no. 3, pp. 275–281, 1996. View at Publisher · View at Google Scholar
  21. L. Soong, J.-C. Xu, and I. S. Grewal et al., “Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection,” Immunity, vol. 4, no. 3, pp. 263–273, 1996. View at Publisher · View at Google Scholar
  22. R. D. Stout and J. Suttles, “The many roles of CD40 in cell-mediated inflammatory responses,” Immunology Today, vol. 17, no. 10, pp. 487–492, 1996. View at Publisher · View at Google Scholar
  23. S. Kumar and R. L. Tarleton, “Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice,” Journal of Immunology, vol. 166, no. 7, pp. 4596–4603, 2001.
  24. D. Martin and R. Tarleton, “Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection,” Immunological Reviews, vol. 201, no. 1, pp. 304–317, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. J. C. S. Aliberti, M. A. G. Cardoso, G. A. Martins, R. T. Gazzinelli, L. Q. Vieira, and J. S. Silva, “Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes,” Infection and Immunity, vol. 64, no. 6, pp. 1961–1967, 1996.
  26. C. A. Hunter, T. Slifer, and F. Araujo, “Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon,” Infection and Immunity, vol. 64, no. 7, pp. 2381–2386, 1996.
  27. D. Chaussabel, F. Jacobs, and J. de Jonge et al., “CD40 ligation prevents Trypanosoma cruzi infection through interleukin- 12 upregulation,” Infection and Immunity, vol. 67, no. 4, pp. 1929–1934, 1999.
  28. M. Chamekh, V. Vercruysse, and M. Habib et al., “Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection,” Infection and Immunity, vol. 73, no. 10, pp. 6552–6561, 2005. View at Publisher · View at Google Scholar · View at PubMed
  29. Y. Suzuki, M. A. Orellana, R. D. Schreiber, and J. S. Remington, “Interferon-γ: the major mediator of resistance against Toxoplasma gondii,” Science, vol. 240, no. 4851, pp. 516–518, 1988. View at Publisher · View at Google Scholar
  30. R. T. Gazzinelli, M. Wysocka, and S. Hayashi et al., “Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii,” Journal of Immunology, vol. 153, no. 6, pp. 2533–2543, 1994.
  31. C. S. Subauste, M. Wessendarp, R. U. Sorensen, and L. E. Leiva, “CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer,” Journal of Immunology, vol. 162, no. 11, pp. 6690–6700, 1999.
  32. G. Reichmann, W. Walker, and E. N. Villegas et al., “The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis,” Infection and Immunity, vol. 68, no. 3, pp. 1312–1318, 2000. View at Publisher · View at Google Scholar
  33. C. S. Subauste and M. Wessendarp, “CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon,” Infection and Immunity, vol. 74, no. 3, pp. 1573–1579, 2006. View at Publisher · View at Google Scholar · View at PubMed
  34. W. G. Ferlin, T. von der Weid, F. Cottrez, D. A. Ferrick, R. L. Coffman, and M. C. Howard, “The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb,” European Journal of Immunology, vol. 28, no. 2, pp. 525–531, 1998. View at Publisher · View at Google Scholar
  35. A. Awasthi, R. Mathur, and A. Khan et al., “CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response,” Journal of Experimental Medicine, vol. 197, no. 8, pp. 1037–1043, 2003. View at Publisher · View at Google Scholar · View at PubMed
  36. G. J. Mazzei, M. D. Edgerton, and C. Losberger et al., “Recombinant soluble trimeric CD40 ligand is biologically active,” Journal of Biological Chemistry, vol. 270, no. 13, pp. 7025–7028, 1995. View at Publisher · View at Google Scholar
  37. R. S. Kornbluth, “The emerging role of CD40 ligand in HIV infection,” Journal of Leukocyte Biology, vol. 68, no. 3, pp. 373–382, 2000.
  38. G. Chen, P. A. Darrah, and D. M. Mosser, “Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages,” Infection and Immunity, vol. 69, no. 5, pp. 3255–3263, 2001. View at Publisher · View at Google Scholar · View at PubMed
  39. W. C. Fanslow, S. Srinivasan, R. Paxton, M. G. Gibson, M. K. Spriggs, and R. J. Armitage, “Structural characteristics of CD40 ligand that determine biological function,” Seminars in Immunology, vol. 6, no. 5, pp. 267–278, 1994. View at Publisher · View at Google Scholar · View at PubMed
  40. R. M. Locksley, N. Killeen, and M. J. Lenardo, “The TNF and TNF receptor superfamilies: integrating mammalian biology,” Cell, vol. 104, no. 4, pp. 487–501, 2001. View at Publisher · View at Google Scholar
  41. A. E. Morris, R. L. Remmele Jr., R. Klinke, B. M. Macduff, W. C. Fanslow, and R. J. Armitage, “Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154),” Journal of Biological Chemistry, vol. 274, no. 1, pp. 418–423, 1999. View at Publisher · View at Google Scholar
  42. S. Fournel, S. Wieckowski, and W. Sun et al., “C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L,” Nature Chemical Biology, vol. 1, no. 7, pp. 377–382, 2005. View at Publisher · View at Google Scholar
  43. M. Habib, M. Noval Rivas, and M. Chamekh et al., “Small CD40L mimetics promote control of parasitemia and enhances T cells producing interferon-γ during experimental Trypanosoma cruzi infection,” to appear in Journal of Immunology.
  44. S. Zambrano-Villa, D. Rosales-Borjas, J. C. Carrero, and L. Ortiz-Ortiz, “How protozoan parasites evade the immune response,” Trends in Parasitology, vol. 18, no. 6, pp. 272–278, 2002. View at Publisher · View at Google Scholar
  45. L. Van Overtvelt, N. Vanderheyde, and V. Verhasselt et al., “Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules,” Infection and Immunity, vol. 67, no. 8, pp. 4033–4040, 1999.
  46. L. Planelles, M. C. Thomas, C. Marañón, M. Morell, and M. C. López, “Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice,” Clinical and Experimental Immunology, vol. 131, no. 1, pp. 41–47, 2003. View at Publisher · View at Google Scholar
  47. R. K. Mathur, A. Awasthi, P. Wadhone, B. Ramanamurthy, and B. Saha, “Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses,” Nature Medicine, vol. 10, no. 5, pp. 540–544, 2004. View at Publisher · View at Google Scholar · View at PubMed
  48. K. M. Haas, K. A. Taylor, N. D. MacHugh, J. M. Kreeger, and D. M. Estes, “Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection,” Journal of Leukocyte Biology, vol. 70, no. 6, pp. 931–940, 2001.